The long story of camptothecin: From traditional medicine to drugs.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2017-02-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2016.12.085PMID 28073672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy

  2016cited by this paper
• Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis

  2016cited by this paper
• Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads.

  2016cited by this paper
• Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan

  2016cited by this paper
• Compound Specific Extraction of Camptothecin from Nothapodytes nimmoniana and Piperine from Piper nigrum Using Accelerated Solvent Extractor

  2014cited by this paper
• Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug.

  2013cited by this paper
• New and highly efficient column chromatographic extraction and simple purification of camptothecin from Camptotheca acuminata and Nothapodytes pittosporoides.

  2013cited by this paper
• Identification of repurposed small molecule drugs for chordoma therapy

  2013cited by this paper
• Camptothecins

  2012cited by this paper
• Namitecan: a hydrophilic camptothecin with a promising preclinical profile.

  2012cited by this paper
• Recent progress in the diagnosis and treatment of ovarian cancer

  2011cited by this paper
• Cancer therapies utilizing the camptothecins: a review of the in vivo literature.

  2010cited by this paper
• Production of camptothecin in cultures of Chonemorpha grandiflora

  2010cited by this paper
• Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.

  2009cited by this paper
• Homogenate extraction technology of camptothecine and hydroxycamptothecin from Camptotheca acuminata leaves

  2009cited by this paper
• Phase I Trial of Poly-l-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies

  2007cited by this paper
• Topoisomerase I inhibitors: camptothecins and beyond

  2006cited by this paper
• Rubitecan

  2006cited by this paper
• Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies

  2005cited by this paper
• Phase II trial of oral rubitecan in previously treated pancreatic cancer patients.

  2005cited by this paper
• Comparison of techniques for the extraction of the anti-cancer drug camptothecin from Nothapodytes foetida.

  2005cited by this paper
• Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice

  2004cited by this paper
• Gimatecan, a novel camptothecin with a promising preclinical profile

  2004cited by this paper
• The camptothecins.

  2003cited by this paper
• E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin

  2003cited by this paper
• Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan.

  2002cited by this paper
• A practical six-step synthesis of (S)-camptothecin.

  2001cited by this paper
• Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.

  2000cited by this paper
• Pharmacology of Camptothecin Esters

  2000cited by this paper
• Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.

  1999cited by this paper
• A model for the mechanism of human topoisomerase I.

  1998cited by this paper
• Clinical applications of the camptothecins.

  1998cited by this paper
• Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.

  1998cited by this paper
• Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.

  1998cited by this paper
• Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents

  1997cited by this paper
• Topoisomerase I Inhibition by the Camptothecin Analog G1147211C

  1996cited by this paper
• Topoisomerase I inhibition by the camptothecin analog Gl147211C. From the laboratory to the clinic.

  1996cited by this paper
• Synthesis of CPT‐11 (Irinotecan Hydrochloride Trihydrate)

  1996cited by this paper
• Current perspectives on camptothecins in cancer treatment.

  1996cited by this paper
• Tandem radical reactions of isonitriles with 2-pyridonyl and other aryl radicals: Scope and limitations, and a first generation synthesis of (±)-camptothecin

  1996cited by this paper
• In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.

  1995cited by this paper
• Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.

  1995cited by this paper
• Camptothecins New Anticancer Agents

  1994cited by this paper
• A six-step synthesis of (±) camptothecin

  1994cited by this paper
• Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

  1994cited by this paper
• Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.

  1993cited by this paper
• Concise total syntheses of dl-camptothecin and related anticancer drugs

  1993cited by this paper
• Inhibitory Activity of Camptothecin Derivatives Against Acetylcholinesterase in Dogs and Their Binding Activity to Acetylcholine Receptors in Rats

  1993cited by this paper
• Structural modifications of camptothecin and effects on topoisomerase I inhibition.

  1992cited by this paper
• Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

  1992cited by this paper
• Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.

  1991cited by this paper
• Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.

  1991cited by this paper
• Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity

  1991cited by this paper
• [Phase I clinical study of CPT-11. Research group of CPT-11].

  1990cited by this paper
• The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?

  1990cited by this paper
• Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin.

  1990cited by this paper
• Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity.

  1989cited by this paper
• On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.

  1989cited by this paper
• Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.

  1988cited by this paper
• Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.

  1988cited by this paper
• Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.

  1988cited by this paper
• Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors.

  1987cited by this paper
• Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin.

  1987cited by this paper
• DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators.

  1987cited by this paper
• Plant antitumor agents. 28. Resolution of a key tricyclic synthon, 5'(RS)-1,5-dioxo-5'-ethyl-5'-hydroxy-2'H,5'H,6'H-6'-oxopyrano[3' ,4'- f]delta 6,8-tetrahydro-indolizine: total synthesis and antitumor activity of 20(S)- and 20(R)-camptothecin.

  1987cited by this paper
• Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

  1985cited by this paper
• Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues.

  1980cited by this paper
• Treatment of malignant melanoma with camptothecin (NSC-100880).

  1972cited by this paper
• Treatment of malignant melanoma with camptothecin (NSC-100880).

  1972cited by this paper
• Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

  1972cited by this paper
• Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

  1972cited by this paper
• The total synthesis of dl-camptothecin.

  1971cited by this paper
• Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

  1970cited by this paper
• Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

  1966cited by this paper

• Evolution and Multifunctional Engineering of Photosensitizers: Advancing Precision Cancer Therapy through Photodynamic Combinatorial Strategies

  2026cites this paper
• Camptothecin-PHA nanoparticles attenuate drug-induced gut microbiome dysbiosis and metabolic toxicity

  2026cites this paper
• Redox-Sensitive Camptothecin Prodrug: A Promising Drug Delivery Strategy with Ultrahigh Drug Loading and Tunable Drug Release.

  2025cites this paper
• Orychophragvioline A, a Novel Alkaloid Isolated from Orychophragmus violaceus with Anti-Cervical Cancer Activity

  2025cites this paper
• BIOACTIVE POTENTIAL OF PERSICARIA (L.) Mill. SPECIES

  2025cites this paper
• Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy

  2025cites this paper
• Applications of Precise Chemistry in Drug Discovery★

  2025cites this paper
• Synthesis and investigation of thieno[2,3-b]pyridines that restore activity of topotecan.

  2025cites this paper
• Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments

  2025influential citation
• Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1

  2025cites this paper
• Switchable skeletal editing of quinolines enabled by cyclizative sequential rearrangements

  2025cites this paper
• Blue Fluorescent Siloxytecans Exhibit Potent Anticancer Activity and Enable Direct Real-Time Quantification of Intracellular Uptake.

  2025cites this paper
• Exploring Camptothecin Derivatives from the Chinese Tree of Camptotheca acuminata as Breast Cancer Protease Inhibitors: Insights from Multi-Scale Computational Analysis

  2025cites this paper
• A Glutathione-Responsive L-Carnitine-Modified Camptothecin Oral Nano-Prodrug for Cancer Therapy

  2025cites this paper
• Peptide-drug conjugates with linker-dependent payload release coordinate dual antitumor efficacy: Intrinsic RGDS-mediated metastasis suppression synergizes with camptothecin cytotoxicity.

  2025cites this paper
• Synthesis and antitumor activity of bis-camptothecin ester of succinic acid

  2025cites this paper
• Production of the anticancer drug intermediate strictosidinic acid in engineered yeast

  2025cites this paper
• Skeletal Editing Via CH→N Atom Swapping in Fused Imidazoles: Access to Triazolo[5,1-a]isoquinoline, Triazolo[1,5-a]quinoline, and Triazolo-[1,5-a]pyridines Frameworks.

  2025cites this paper
• Cancer chemoprevention: signaling pathways and strategic approaches

  2025cites this paper
• Spectroscopic and molecular docking studies on binding interactions of camptothecin drugs with bovine serum albumin

  2025cites this paper
• Traditional Chinese Medicine-Based Nanoformulations for Enhanced Photothermal Therapy of Cancer.

  2025cites this paper
• Unveiling the Mechanism of Action of Palmitic Acid, a Human Topoisomerase 1B Inhibitor from the Antarctic Sponge Artemisina plumosa

  2025cites this paper
• A practical and easy‐to‐scale protocol for removing chlorophylls from leaf extracts

  2025cites this paper
• A patent review of topoisomerase 1 inhibitors (2021–present)

  2025cites this paper
• Validating TDP1 as an Inhibition Target for Lipophilic Nucleoside Derivative in Human Cells

  2025cites this paper
• Targeting Skp2 by camptothecin induces p27 accumulation and confers drug resistance in non-small cell lung cancer.

  2025cites this paper
• Smart polymer prodrugs via responsive prodrug-initiated ring-opening polymerization of lactide for improved drug delivery.

  2025cites this paper
• Clinical Outcomes and Effectiveness of CRLX101 for Solid Tumors: A Systematic Review and Meta-analysis.

  2024cites this paper
• Drug combinations of camptothecin derivatives promote the antitumor properties.

  2024cites this paper
• Exploring anticancer properties of the phytoconstituents and comparative analysis of their chemical space parameters with USFDA‐approved synthetic anticancer agents

  2024cites this paper
• Emerging Role of Natural Topoisomerase Inhibitors as Anticancer agents.

  2024cites this paper
• Endophytic fungi as a potential source of anti-cancer drug

  2024cites this paper
• FL118 Enhances Therapeutic Efficacy in Colorectal Cancer by Inhibiting the Homologous Recombination Repair Pathway through Survivin–RAD51 Downregulation

  2024cites this paper
• Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy

  2024influential citation
• Synthesis and evaluation of homocamptothecin antibody-drug conjugates for cancer treatment.

  2024cites this paper
• Human health benefits of the goji berry plant, known as the superfruit

  2024cites this paper
• Unlocking Natural Potential: Antibody‐Drug Conjugates With Naturally Derived Payloads for Cancer Therapy

  2024cites this paper
• Identification of 7-aminourea or 7-aminothiourea derivatives of camptothecin as selective topoisomerase I inhibitors with anti-colorectal cancer activities.

  2024cites this paper
• Selenization of Small Molecule Drugs: A New Player on the Board.

  2024cites this paper
• Unveiling the potential of Chinese herbs in combating cervical cancer: Understanding their mechanisms of action and herbal formulations

  2024cites this paper
• Quinoline-based compounds can inhibit diverse enzymes that act on DNA.

  2024cites this paper
• Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway.

  2024cites this paper
• Efficient Strategy to Synthesize Tunable pH-Responsive Hybrid Micelles Based on Iron Oxide and Gold Nanoparticles

  2024cites this paper
• Historical Perspective and Current Trends in Anticancer Drug Development

  2024cites this paper
• Biotechnological approaches for the production of camptothecin

  2024cites this paper
• Exploring the Role of Target Expression in Treatment Efficacy of Antibody–Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review

  2024cites this paper
• Natural products - Dawn of keloid treatment.

  2024cites this paper
• Bovine serum albumin-Camptothecin nanoparticles for RNAs packaging to improve the prognosis of Cancer.

  2024cites this paper
• Alkaloids in Cancer therapy: Targeting the tumor microenvironment and metastasis signaling pathways.

  2024cites this paper
• Recent progress in the development of peptide-drug conjugates (PDCs) for cancer therapy.

  2024cites this paper
• The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer

  2024cites this paper
• Recent advancements in natural compounds for cancer therapy and prevention

  2024cites this paper
• Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer

  2024cites this paper
• Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K/AKT/mTOR pathway.

  2024cites this paper
• The role of silicon in drug discovery: a review

  2024cites this paper
• Antibacterial activity of medicinal plants and their role in wound healing

  2024cites this paper
• The Effect of Lipid Composition on the Liposomal Delivery of Camptothecin Developed by Active Click Loading.

  2024cites this paper
• Phosphine Oxide Indenoquinoline Derivatives: Synthesis and Biological Evaluation as Topoisomerase I Inhibitors and Antiproliferative Agents

  2024cites this paper
• Therapeutic applications of RNA nanostructures

  2024cites this paper
• Medical Jeopardy Quiz: Medicinal plants.

  2024cites this paper
• An alternative synthesis for Exatecan mesylate

  2024cites this paper
• Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies

  2024cites this paper
• Selagibenzophenone B and Its Derivatives: SelB-1, a Dual Topoisomerase I/II Inhibitor Identified through In Vitro and In Silico Analyses

  2024cites this paper
• Recent Advances in the Synthesis of Rosettacin

  2024cites this paper
• A self-assembling conjugate of SN38 with aminoguanidine for simultaneously suppressing proliferation and migration of breast cancer cells

  2024cites this paper
• Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements.

  2024cites this paper
• Functional characterization of Camptotheca acuminata 7-deoxyloganetic acid synthases and 7-deoxyloganetic acid glucosyltransferases involved in camptothecin biosynthesis.

  2024cites this paper
• Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy.

  2023cites this paper
• The Advancement of Biodegradable Polyesters as Delivery Systems for Camptothecin and Its Analogues—A Status Report

  2023influential citation
• First record of the genus Camptotheca (Nyssaceae) in Vietnam and the lectotypification of C.acuminata

  2023cites this paper
• Stimulus‐Responsive Nano‐Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery

  2023cites this paper
• Research on GGT-responsive drug carrier with active transport effect

  2023cites this paper
• Is Target-Based Drug Discovery Efficient? Discovery and "Off-Target" Mechanisms of All Drugs.

  2023cites this paper
• Catalytic Site Constraints in the P450s Mediating Loganic Acid (7DLH) and Secologanic Acid Synthesis (SLAS) in Camptotheca.

  2023cites this paper
• Tag and Snag: A New Platform for Bioactive Natural Product Screening from Mixtures

  2023cites this paper
• Role of the transcription factor Fli-1 on the CXCL10/CXCR3 Axis*

  2023cites this paper
• Camptothecin-based prodrug nanomedicines for cancer therapy.

  2023cites this paper
• The recent developments of camptothecin and its derivatives as potential anti-tumor agents.

  2023cites this paper
• Synthesis and Antitumor Evaluation of Biotin-SN38-Valproic Acid Conjugates

  2023cites this paper
• Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers

  2023cites this paper
• Structural Modification Endows Small-Molecular SN38 Derivatives with Multifaceted Functions

  2023cites this paper
• Internet-Connected Cortical Organoids for Project-Based Stem Cell and Neuroscience Education

  2023cites this paper
• Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapy.

  2023cites this paper
• Peptide cargo administration: current state and applications

  2023cites this paper
• Improved anti-tumor activity of fluorinated camptothecin derivatives 9-fluorocamptothecin and 7-ethyl-9-fluorocamptothecin on hepatocellular carcinoma by targeting topoisomerase I.

  2023cites this paper
• Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors

  2023cites this paper
• Tyrosyl-DNA phosphodiesterase 1 (TDP1) and SPRTN protease repair histone 3 and topoisomerase 1 DNA–protein crosslinks in vivo

  2023cites this paper
• Chelerythrine, a novel small molecule targeting IL-2, inhibits melanoma progression by blocking the interaction between IL-2 and its receptor.

  2023cites this paper
• Recent advances in SN-38 drug delivery system.

  2023cites this paper
• Synthesis and SAR of Potential Anti-Cancer Agents of Quinoline Analogues: A Review.

  2023cites this paper
• High conservation of the core eudicots ancient genome likely by paleo-autotetraploidization-resulted Arcto-Tertiary relict plant family Nyssaceae

  2023cites this paper
• Synergistic effects of chlorantraniliprole and camptothecin on physiological impairments, histopathological, biochemical changes, and genes responses in the larvae midgut of Spodoptera frugiperda.

  2023cites this paper
• Current Prospects and Clinical Status of Microalgae Derived Chemotherapeutics

  2023cites this paper
• Tyloxapol and nanoliposomes induce selective delivery of 5‐fluorouracil into hepatic tissues via VLDL/LDL‐mediated pathway

  2023cites this paper
• Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation

  2022influential citation
• A Critical Analysis of Drugs Used in Anticancer Therapy Isolated from the Catharanthus roseus : A Review

  2022cites this paper
• The naturally‐derived alkaloids as a potential treatment for COVID‐19: A scoping review

  2022cites this paper
• Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges

  2022cites this paper
• Dual-Functional Polymeric Micelles Co-Loaded with Antineoplastic Drugs and Tyrosine Kinase Inhibitor for Combination Therapy in Colorectal Cancer

  2022cites this paper
• Thiol-Michael addition based conjugate for glutathione activation and release.

  2022cites this paper